SMS Lifesciences India Limited (SMSLIFE.NS)

INR 1540.0

(-5.28%)

Net Debt Summary of SMS Lifesciences India Limited

SMS Lifesciences India Limited's latest annual net debt in 2023 was 992.31 Million INR , up 14.26% from previous year.
SMS Lifesciences India Limited's latest quarterly net debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
SMS Lifesciences India Limited reported annual net debt of 868.46 Million INR in 2022, up 10.48% from previous year.
SMS Lifesciences India Limited reported annual net debt of 786.11 Million INR in 2021, up 40.0% from previous year.
SMS Lifesciences India Limited reported quarterly net debt of 992.31 Million INR for 2023 FY, up 14.26% from previous quarter.
SMS Lifesciences India Limited reported quarterly net debt of 992.31 Million INR for 2023 Q4, up 4972.4% from previous quarter.

Annual Net Debt Chart of SMS Lifesciences India Limited (2023 - 2015)

Historical Annual Net Debt of SMS Lifesciences India Limited (2023 - 2015)

Year	Net Debt	Net Debt Growth
2023	992.31 Million INR	14.26%
2022	868.46 Million INR	10.48%
2021	786.11 Million INR	40.0%
2020	561.49 Million INR	-10.07%
2019	624.37 Million INR	39.0%
2018	449.18 Million INR	66.88%
2017	269.17 Million INR	15.52%
2016	233.01 Million INR	-33.7%
2015	351.47 Million INR	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	- INR	-100.0%
2023 FY	992.31 Million INR	14.26%
2023 Q4	992.31 Million INR	4972.4%
2023 Q3	19.56 Million INR	-97.92%
2023 Q2	941.61 Million INR	2033.82%
2023 Q1	44.12 Million INR	-94.92%
2022 Q2	904.95 Million INR	1960.47%
2022 FY	868.46 Million INR	10.48%
2022 Q4	868.46 Million INR	2011.67%
2022 Q3	41.12 Million INR	-95.46%
2022 Q1	43.92 Million INR	-94.41%
2021 Q2	622.7 Million INR	462.83%
2021 Q4	786.11 Million INR	1620.95%
2021 Q1	110.63 Million INR	-80.3%
2021 Q3	45.67 Million INR	-92.66%
2021 FY	786.11 Million INR	40.0%
2020 Q2	710.85 Million INR	836.1%
2020 FY	561.49 Million INR	-10.07%
2020 Q4	561.49 Million INR	826.45%
2020 Q3	60.6 Million INR	-91.47%
2020 Q1	75.93 Million INR	-87.84%
2019 Q3	50.35 Million INR	-88.64%
2019 Q2	443.27 Million INR	1597.67%
2019 Q1	26.11 Million INR	-94.19%
2019 FY	624.37 Million INR	39.0%
2019 Q4	624.37 Million INR	1139.87%
2018 FY	449.18 Million INR	66.88%
2018 Q3	6.6 Million INR	-97.39%
2018 Q4	449.18 Million INR	6700.71%
2018 Q1	9.03 Million INR	-96.64%
2018 Q2	252.73 Million INR	2697.26%
2017 FY	269.17 Million INR	15.52%
2017 Q2	181.2 Million INR	522.99%
2017 Q4	269.17 Million INR	0.0%
2017 Q1	29.08 Million INR	-87.52%
2016 FY	233.01 Million INR	-33.7%
2016 Q4	233.01 Million INR	0.0%
2016 Q1	16 Thousand INR	0.0%
2015 FY	351.47 Million INR	0.0%

Peer Net Debt Comparison of SMS Lifesciences India Limited

Name	Net Debt	Net Debt Difference
Biocon Limited	140.18 Billion INR	99.292%
Blue Jet Healthcare Limited	-830.93 Million INR	219.422%
Concord Biotech Limited	-54.04 Million INR	1936.087%
Dishman Carbogen Amcis Limited	18.99 Billion INR	94.775%
Jubilant Ingrevia Limited	6.6 Billion INR	84.98%
Lyka Labs Limited	527.01 Million INR	-88.29%
Panacea Biotec Limited	-1.18 Billion INR	183.747%
Piramal Pharma Limited	42.27 Billion INR	97.653%
Supriya Lifescience Limited	-694.68 Million INR	242.845%
Syngene International Limited	-83 Million INR	1295.558%
TAKE Solutions Limited	361.37 Million INR	-174.598%
Zota Health Care Limited	942.79 Million INR	-5.252%